Kenvue Inc. (KVUE) · Nov 4, 2026 · Acquisition
$7B debt exchange — Up to $7.0B of Kenvue notes exchanged for Kimberly-Clark notes and cash
Kenvue’s acquisition, delisting and $7 billion debt exchange are now complete, ending its standalone public-company story while loosening noteholder protections.
Kenvue was already being absorbed into Kimberly-Clark through the previously announced acquisition that created a combined consumer-health and personal-care company; Kimberly-Clark announced the transaction had closed on November 2, 2026, with Kenvue shares ceasing to trade that morning. This filing is mainly the legal completion notice, not a new strategic surprise. The NYSE had already filed the delisting notice, with formal delisting scheduled for November 12. 〔0〕
The meaningful new detail is on the debt side: Kenvue’s notes are being shifted into the Kimberly-Clark financing structure. Holders tendered up to $7.0 billion of Kenvue notes for new Kimberly-Clark notes and cash, and the accepted Kenvue notes were retired rather than reissued. 〔1〕
That refinancing also weakens protections for any Kenvue notes left outstanding. The amendments eliminate substantially all restrictive covenants, remove several non-payment events of default, eliminate the SEC reporting covenant and loosen restrictions on mergers or asset transfers. 〔2〕 〔3〕 This is negative for creditor protection, but it is part of the already telegraphed merger mechanics rather than a surprise to the equity story.
Bottom line: Kenvue’s standalone public-company story is now over, while its debt is being reorganized under Kimberly-Clark with lighter protections for remaining holders. The filing matters operationally, but mostly confirms an outcome the market already knew was coming.
Kimberly-Clark integration and combined-company reporting
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!